Santa Barbara Nutrients welcomes inquiries from healthcare practitioners and researchers interested in proposing clinical studies involving KetoCitra® or the Ren-Nu program. Studies may range from individual case reports to controlled clinical trials. Areas of interest include metabolic diseases and conditions that may benefit from KetoCitra®, including—but not limited to—kidney disease, mental health conditions, and cancer.
SBN may support approved studies through the provision of KetoCitra® and placebo, assistance with ethics approvals, grant writing, regulatory tasks, and, where appropriate, funding support.
Contact SBN’s Director of Clinical Research:
Emily Muensterman — muensterman@sbnutrients.com